Filter
719
Text search:
drug
formulations
Featured
Recommendations
91
New Publications
210
Language
Document type
No document type
399
Guidelines
150
Studies & Reports
94
Manuals
37
Training Material
13
Strategic & Response Plan
10
Fact sheets
9
Situation Updates
2
Resource Platforms
2
Brochures
1
App
1
Infographics
1
Countries / Regions
India
51
Kenya
28
Global
23
Ethiopia
15
South Africa
15
Malawi
15
Western and Central Europe
12
Africa
12
Tanzania
11
Uganda
10
Nepal
10
Bangladesh
10
Sierra Leone
9
Nigeria
8
Zimbabwe
8
Zambia
8
Namibia
8
Liberia
7
Ghana
7
Philippines
7
Rwanda
7
Myanmar / Burma
7
South–East Asia Region
6
Latin America and the Carribbean
6
Eastern Europe
6
Cameroon
4
Cambodia
4
Eswatini/ Swaziland
4
Senegal
3
Haiti
3
Syria
3
Benin
3
Botswana
3
Burkina Faso
2
Indonesia
2
East and Southern Africa
2
Middle East and North Africa
2
Russia
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Pakistan
1
South Sudan
1
Afghanistan
1
Thailand
1
Malaysia
1
Mozambique
1
Argentina
1
Peru
1
Brazil
1
Ukraine
1
Colombia
1
Bolivia
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Australia
1
Georgia
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
258
Clinical Guidelines
129
Women & Child Health
33
Public Health
32
Key Resources
19
Pharmacy & Technologies
15
Capacity Building
9
Toolboxes
HIV
105
TB
92
Pharmacy
63
AMR
40
Mental Health
32
NTDs
32
COVID-19
15
NCDs
15
Malaria
13
Rapid Response
9
Caregiver
9
Ebola & Marburg
8
Refugee
5
Planetary Health
5
Disability
4
Conflict
4
2.0 Rapid Response
4
Cholera
3
Polio
3
Health Financing Toolbox
3
Zika
2
Specific Hazards
2
Global Health Education
2
Seizures constitute the most common neurological problem in children and the majority of epilepsy has its onset in childhood. Appropriate diagnosis and management of childhood epilepsy is essential to improve quality of life in these children. Evidence-based clinical practice guidelines, modified to
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio
...
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of
...
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an
...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
